| Clinical event |
Ondansetron (n = 32)
n (%) |
Placebo (n = 33)
n (%) |
p (1df) |
| Nothing reported |
13 (40.62) |
17 (51.51) |
χ2 = 0.77, p = 0.38 |
| Somnolence |
1 (3.12) |
0 |
χ2 = 1.05, p = 0.49 |
| Headache |
5 (15.62) |
5 (15.15) |
χ2 < 0.01, p > 0.99 |
| Dyspepsia |
2 (6.25) |
3 (9.09) |
χ2 = 0.18, p > 0.99 |
| Diarrhea |
1 (3.12) |
2 (6.06) |
χ2 = 0.32, p > 0.99 |
| Constipation |
5 (15.62) |
1 (3.03) |
χ2 = 3.08, p = 0.10 |
| Genitourinary symptoms |
1 (3.12) |
2 (6.06) |
χ2 = 0.32, p > 0.99 |
| Pruritus |
2 (6.25) |
2 (6.06) |
χ2 < 0.01, p > 0.09 |
|
